Byron Kemper

7.8k citations
110 papers · 6.5k indexed · 4 hit papers · h-index 42
Topics
Pharmacogenetics and Drug Metabolism (37 papers)Drug Transport and Resistance Mechanisms (26 papers)Metabolism, Diabetes, and Cancer (19 papers)
Partner nations
United StatesFranceJapan

In The Last Decade

Byron Kemper

110 papers receiving 6.2k citations

Hit Papers

Single-stranded DNA ‘blue’ T7 promoter plasmids: a versat...19862026199920121986198719892014250500750

Peers

Byron Kemper
Comparison fields: 5 of 121
  • Molecular Biology 3.6k
  • Pharmacology 1.7k
  • Oncology 1.3k
  • Genetics 1.0k
  • Epidemiology 914
Replace Thierry Pineau with:
Thierry Pineau France
Charles N. Falany United States
Karen T. Liby United States
Colin R. Jefcoate United States
Gabriella Leonarduzzi Italy
Jun‐ichi Sawada Japan
Hideaki Kamata Japan
Christopher E. Goldring United Kingdom
Sung Hwan Ki South Korea
Abdellah Mansouri France
Byron Kemper relative to Thierry Pineau France Thierry Pineau's profile →
Citations per field
00.5×1.6×
Thierry Pineau · 1×
Citations per year

Countries citing papers authored by Byron Kemper

Since Specialization
Citations

This map shows the geographic impact of Byron Kemper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron Kemper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron Kemper more than expected).

Fields of papers citing papers by Byron Kemper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byron Kemper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron Kemper. The network helps show where Byron Kemper may publish in the future.

Co-authorship network of co-authors of Byron Kemper

This figure shows the co-authorship network connecting the top 25 collaborators of Byron Kemper. A scholar is included among the top collaborators of Byron Kemper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byron Kemper. Byron Kemper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 60
3 111
4 1
5 12
6 36
7 51
8 44
9 69
10 39
11 42
12 18
13 37
14 13
15 12
16 42
17
The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Locibreakdown →
521
18
The P450 Gene Superfamily: Recommended Nomenclaturebreakdown →
657
19 17
20 15

About Byron Kemper

Byron Kemper is a scholar working on Pharmacology, Molecular Biology and Oncology, having authored 110 papers that have together received 6.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (37 papers), Drug Transport and Resistance Mechanisms (26 papers) and Metabolism, Diabetes, and Cancer (19 papers). The work is most often cited by research in Pharmacology (1.7k citations), Biochemistry (450 citations) and Molecular Biology (3.6k citations). Byron Kemper has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Elzbieta Szczesna-Skorupa, David A. Mead, Jongsook Kim Kemper, Joel F. Habener, John T. Potts, Sunmi Seok, Eric F. Johnson, Alexander Rich, Frank J. Gonzalez and Wayne Levin. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026